136 related articles for article (PubMed ID: 28834443)
1. Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
Wu CJ; Zhang YD; Bao ML; Li H; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2017 Nov; 209(5):1081-1087. PubMed ID: 28834443
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
BJU Int; 2017 Jan; 119(1):57-66. PubMed ID: 26823024
[TBL] [Abstract][Full Text] [Related]
4. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer.
Wang Q; Li H; Yan X; Wu CJ; Liu XS; Shi HB; Zhang YD
Urol Oncol; 2015 Aug; 33(8):337.e15-24. PubMed ID: 26048104
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
7. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging-Based Prostate-Specific Antigen Density for Prediction of Gleason Score Upgrade in Patients With Low-Risk Prostate Cancer on Initial Biopsy.
Sim KC; Sung DJ; Kang KW; Yang KS; Han NY; Park BJ; Kim MJ; Cho SB
J Comput Assist Tomogr; 2017; 41(5):731-736. PubMed ID: 28914751
[TBL] [Abstract][Full Text] [Related]
9. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
13. Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?
Faletti R; Battisti G; Discalzi A; Grognardi ML; Martinello S; Oderda M; Gontero P; Bergamasco L; Cassinis MC; Fonio P
Abdom Radiol (NY); 2016 May; 41(5):926-33. PubMed ID: 27193791
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
[TBL] [Abstract][Full Text] [Related]
15. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.
Caivano R; Rabasco P; Lotumolo A; Cirillo P; D'Antuono F; Zandolino A; Villonio A; Macarini L; Salvatore M; Cammarota A
Cancer Invest; 2013 Nov; 31(9):625-9. PubMed ID: 24138289
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
[TBL] [Abstract][Full Text] [Related]
17. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results.
Quentin M; Pentang G; Schimmöller L; Kott O; Müller-Lutz A; Blondin D; Arsov C; Hiester A; Rabenalt R; Wittsack HJ
Magn Reson Imaging; 2014 Sep; 32(7):880-5. PubMed ID: 24848289
[TBL] [Abstract][Full Text] [Related]
19. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
[TBL] [Abstract][Full Text] [Related]
20. The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.
Nougaret S; Robertson N; Golia Pernicka J; Molinari N; Hötker AM; Ehdaie B; Sala E; Hricak H; Vargas HA
Abdom Radiol (NY); 2017 Jul; 42(7):1968-1974. PubMed ID: 28258355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
